Study of Meniscal Allografts
- Conditions
- Meniscectomy Sequelae
- Interventions
- Procedure: Meniscal Allograft
- Registration Number
- NCT01059409
- Lead Sponsor
- Assistance Publique - H么pitaux de Paris
- Brief Summary
Total or subtotal meniscectomies in young patients are currently responsible of pain and limitation of activities. There isn't any other treatment than meniscal replacement. But there is no randomized clinical trial on meniscal allograft to validate the efficiency of this treatment.
- Detailed Description
Meniscal allograft is done through United States and Europe since the last fifteen years. Operative technique has regularly improved, especially because of new arthroscopic devices. The meniscal allografts to be used are taken from dead donors and then frozen according to all the reglementary aspects of tissue bank.
The graft has to be ordered as soon as the patient is randomized ; the sizing of the graft ordered is important depending on the gender size and height of the patient and on the measures of the tibial plateau on X Rays.
The arthroscopic procedure is done under general or loco-regional anesthesia. The graft has to be prepared with bone blocks attached to the anterior and posterior horn of the meniscal graft. These bone blocks will be fixed through bone tunnels and the meniscus itself will be sutured on the peripheral meniscus synovial rim.
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 23
- Age from 18 on
- Previous total or subtotal meniscectomy
- Medical insurance
- Female patients have to be under contraceptive treatment
- Sign consent form
- Age < 18 years
- Pregnant or breast-feeding woman
- Need of a simultaneous frontal osteotomy
- Inflammatory disease
- Septic background
- Psychiatric background
- Understanding difficulties or problems for follow-up
- No consent
- No medical insurance
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Meniscal Allograft Meniscal Allograft -
- Primary Outcome Measures
Name Time Method "Function" Subscale in the Koos Scale (area under the curve) 2 years follow up Koos Scale
- Secondary Outcome Measures
Name Time Method Clinical criteria: pain, quality of life, professional activity At 2 years follow-up Pain, quality of life, professional activity
Post operative and late complications At 2 years follow-up Post operative complications
Trial Locations
- Locations (2)
POTEL Jean-Fran莽ois, Clinique Medipole Garonne
馃嚝馃嚪Toulouse, France
H么pital Avicenne - Service de Chirurgie orthop茅dique
馃嚝馃嚪Bobigny, Ile De France, France